loading...| Preferred Name | Risedronate Sodium | |
| Synonyms |
|
|
| Definitions |
The sodium salt of risedronic acid, a synthetic pyridinyl bisphosphonate. Risedronic acid binds to hydroxyapatite crystals in bone and inhibits osteoclast-dependent bone resorption. |
|
| ID |
http://purl.obolibrary.org/obo/NCIT_C1528 |
|
| Accepted_Therapeutic_Use_For |
Osteoporosis, treatment and prevention; Pagets disease |
|
| ALT_DEFINITION |
A substance that is being studied in the prevention and treatment of osteoporosis. It belongs to the family of drugs called bone resorption inhibitors. |
|
| CAS_Registry |
115436-72-1 |
|
| Chemical_Formula |
C7H10NO7P2.Na |
|
| code |
C1528 |
|
| Contributing_Source |
CTRP FDA |
|
| definition |
The sodium salt of risedronic acid, a synthetic pyridinyl bisphosphonate. Risedronic acid binds to hydroxyapatite crystals in bone and inhibits osteoclast-dependent bone resorption. |
|
| Display_Name |
Risedronate Sodium |
|
| FDA_UNII_Code |
OFG5EXG60L |
|
| Has_Free_Acid_Or_Base_Form | ||
| in_subset |
http://purl.obolibrary.org/obo/NCIT_C63923 http://purl.obolibrary.org/obo/NCIT_C176424 |
|
| label |
Risedronate Sodium |
|
| Legacy Concept Name |
Risedronate_Sodium |
|
| NCI_Drug_Dictionary_ID |
256445 |
|
| NSC Number |
722598 |
|
| PDQ_Closed_Trial_Search_ID |
256445 |
|
| PDQ_Open_Trial_Search_ID |
256445 |
|
| Preferred_Name |
Risedronate Sodium |
|
| prefixIRI |
NCIT:C1528 |
|
| prefLabel |
Risedronate Sodium |
|
| Semantic_Type |
Organic Chemical Pharmacologic Substance |
|
| UMLS_CUI |
C0166025 |
|
| subClassOf |